AYUSH Patent Filings Jump Eightfold: Trends and Data
Recent official data highlights a dramatic expansion in AYUSH patent applications across India over the past decade. According to the government report, inventors filed 4,077 patent applications between FY 2014–15 and FY 2025–26. Moreover, patent authorities granted 711 patents during this twelve-year period. This substantial increase demonstrates an evolving research ecosystem in traditional medicine. Consequently, Indian healthcare stakeholders now observe a stronger convergence between indigenous formulations and contemporary intellectual property standards.
Trends in AYUSH Patent Applications and Approvals
Annual filings rose from 63 applications in FY 2014–15 to 590 applications in FY 2025–26. Therefore, filings grew by approximately 836.5 percent over the evaluated twelve-year window. Filings actually peaked at 606 applications in FY 2022–23. Subsequently, numbers dropped to 299 in FY 2023–24 before rebounding sharply to 590. Concurrently, annual patent grants surged from just 3 in FY 2015–16 to 204 in FY 2023–24. Thus, intellectual property agencies have expedited evaluation processes for traditional therapeutic innovations.
Post-Pandemic Acceleration and Applicant Profiles
Notably, the post-COVID period accounts for seventy percent of all submitted filings. Innovators submitted 2,854 applications between FY 2020–21 and FY 2025–26 alone. In contrast, researchers filed only 1,223 applications in the preceding six years. Furthermore, the post-COVID period yielded 657 patent grants, representing 92.4 percent of all approvals. Natural persons led this surge by contributing 2,113 filings and securing 398 patents. Additionally, academic institutions lodged 995 applications and obtained 88 grants. Small entities and startups together contributed 269 applications. Corporate enterprises added another 700 filings and earned 176 patents.
Clinical Implications for Indian Medical Practice
Modern clinical practice increasingly demands rigorous scientific evidence for traditional remedies. Therefore, patenting offers vital incentives for systematic pharmacological testing and standardization. In addition, patent documentation provides clinical researchers with clear formulation data and preparation methods. This transparency helps physicians evaluate therapeutic claims with greater scientific objectivity. Furthermore, formal intellectual property safeguards indigenous botanical formulations from biopiracy and exploitation. As a result, robust patent activity fosters greater interdisciplinary collaboration between allopathic practitioners and AYUSH researchers, aligning closely with standards taught in structured general practice programs.
Frequently Asked Questions
Q1: What drove the sharp rise in AYUSH patent filings after 2020?
Heightened public and clinical interest during the COVID-19 pandemic accelerated dedicated research into traditional therapeutics. Consequently, institutions and independent innovators scaled up patent filings to validate formulations scientifically.
Q2: Who files the majority of AYUSH patent applications in India?
Natural persons and educational institutions represent the largest share. Together, these two categories account for 76.3 percent of all submitted applications.
Q3: Why is patent protection significant for traditional medicine?
Patents encourage rigorous standardization and protect indigenous botanical heritage from exploitation. Furthermore, formal intellectual property frameworks support evidence generation and clinical research collaborations.
References
- AYUSH sees rise in patents filings showcasing innovation growth; 4,077applications filed from 2014 to 2026 - ETHealthworld
- Ayush Innovation Sees Eightfold Rise in Patent Filings - Press Information Bureau
- Status Report on Ayush Related Inventions in India (2014–2026) - Office of the Controller General of Patents, Designs & Trademarks (CGPDTM), DPIIT
